nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—CYP1A2—Dacarbazine—pancreatic cancer	0.121	0.327	CbGbCtD
Phenylephrine—CYP1A2—Tamoxifen—pancreatic cancer	0.0963	0.26	CbGbCtD
Phenylephrine—CYP1A2—Erlotinib—pancreatic cancer	0.0819	0.221	CbGbCtD
Phenylephrine—CYP1A2—Fluorouracil—pancreatic cancer	0.071	0.192	CbGbCtD
Phenylephrine—Arrhythmia—Sunitinib—pancreatic cancer	0.00157	0.00315	CcSEcCtD
Phenylephrine—Loss of consciousness—Erlotinib—pancreatic cancer	0.00155	0.00311	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Gemcitabine—pancreatic cancer	0.00154	0.0031	CcSEcCtD
Phenylephrine—Hypertension—Tamoxifen—pancreatic cancer	0.00154	0.00309	CcSEcCtD
Phenylephrine—Extravasation—Epirubicin—pancreatic cancer	0.00154	0.00309	CcSEcCtD
Phenylephrine—Myocardial infarction—Gemcitabine—pancreatic cancer	0.00154	0.00309	CcSEcCtD
Phenylephrine—Mental disorder—Sunitinib—pancreatic cancer	0.00154	0.00309	CcSEcCtD
Phenylephrine—Stinging—Doxorubicin—pancreatic cancer	0.00153	0.00308	CcSEcCtD
Phenylephrine—Visual disturbance—Docetaxel—pancreatic cancer	0.00152	0.00306	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.00152	0.00305	CcSEcCtD
Phenylephrine—Chest pain—Tamoxifen—pancreatic cancer	0.00152	0.00305	CcSEcCtD
Phenylephrine—Myocardial infarction—Fluorouracil—pancreatic cancer	0.00151	0.00304	CcSEcCtD
Phenylephrine—Chest pain—Erlotinib—pancreatic cancer	0.0015	0.00302	CcSEcCtD
Phenylephrine—Dysgeusia—Sunitinib—pancreatic cancer	0.00149	0.003	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00149	0.003	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Epirubicin—pancreatic cancer	0.00148	0.00298	CcSEcCtD
Phenylephrine—Bradycardia—Irinotecan—pancreatic cancer	0.00147	0.00295	CcSEcCtD
Phenylephrine—Lacrimation increased—Epirubicin—pancreatic cancer	0.00145	0.00292	CcSEcCtD
Phenylephrine—Extravasation—Doxorubicin—pancreatic cancer	0.00142	0.00286	CcSEcCtD
Phenylephrine—Shock—Erlotinib—pancreatic cancer	0.00141	0.00284	CcSEcCtD
Phenylephrine—Nervous system disorder—Erlotinib—pancreatic cancer	0.00141	0.00284	CcSEcCtD
Phenylephrine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00141	0.00283	CcSEcCtD
Phenylephrine—Skin disorder—Erlotinib—pancreatic cancer	0.0014	0.00281	CcSEcCtD
Phenylephrine—Visual impairment—Irinotecan—pancreatic cancer	0.00139	0.0028	CcSEcCtD
Phenylephrine—Atrioventricular block—Epirubicin—pancreatic cancer	0.00138	0.00278	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Doxorubicin—pancreatic cancer	0.00137	0.00276	CcSEcCtD
Phenylephrine—Neck pain—Epirubicin—pancreatic cancer	0.00136	0.00273	CcSEcCtD
Phenylephrine—Lacrimation increased—Doxorubicin—pancreatic cancer	0.00135	0.00271	CcSEcCtD
Phenylephrine—Cardiac disorder—Irinotecan—pancreatic cancer	0.00134	0.00269	CcSEcCtD
Phenylephrine—Abdominal pain upper—Docetaxel—pancreatic cancer	0.00132	0.00265	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.00132	0.00265	CcSEcCtD
Phenylephrine—Hypertension—Sunitinib—pancreatic cancer	0.00132	0.00265	CcSEcCtD
Phenylephrine—Angiopathy—Irinotecan—pancreatic cancer	0.00131	0.00263	CcSEcCtD
Phenylephrine—Paraesthesia—Tamoxifen—pancreatic cancer	0.00131	0.00262	CcSEcCtD
Phenylephrine—Cardiac disorder—Gemcitabine—pancreatic cancer	0.0013	0.00262	CcSEcCtD
Phenylephrine—Immune system disorder—Irinotecan—pancreatic cancer	0.0013	0.00262	CcSEcCtD
Phenylephrine—Mediastinal disorder—Irinotecan—pancreatic cancer	0.0013	0.00262	CcSEcCtD
Phenylephrine—Chest pain—Sunitinib—pancreatic cancer	0.0013	0.00261	CcSEcCtD
Phenylephrine—Dyspnoea—Tamoxifen—pancreatic cancer	0.0013	0.00261	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00129	0.00259	CcSEcCtD
Phenylephrine—Arrhythmia—Irinotecan—pancreatic cancer	0.00129	0.00259	CcSEcCtD
Phenylephrine—Dyspnoea—Erlotinib—pancreatic cancer	0.00128	0.00258	CcSEcCtD
Phenylephrine—Skin exfoliation—Epirubicin—pancreatic cancer	0.00128	0.00257	CcSEcCtD
Phenylephrine—Atrioventricular block—Doxorubicin—pancreatic cancer	0.00128	0.00257	CcSEcCtD
Phenylephrine—Angiopathy—Gemcitabine—pancreatic cancer	0.00128	0.00257	CcSEcCtD
Phenylephrine—Immune system disorder—Gemcitabine—pancreatic cancer	0.00127	0.00255	CcSEcCtD
Phenylephrine—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00127	0.00255	CcSEcCtD
Phenylephrine—Arrhythmia—Gemcitabine—pancreatic cancer	0.00126	0.00253	CcSEcCtD
Phenylephrine—Neck pain—Doxorubicin—pancreatic cancer	0.00126	0.00252	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00125	0.00252	CcSEcCtD
Phenylephrine—Pain—Tamoxifen—pancreatic cancer	0.00124	0.0025	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00124	0.0025	CcSEcCtD
Phenylephrine—Arrhythmia—Fluorouracil—pancreatic cancer	0.00124	0.00248	CcSEcCtD
Phenylephrine—Pain—Erlotinib—pancreatic cancer	0.00123	0.00247	CcSEcCtD
Phenylephrine—Shock—Sunitinib—pancreatic cancer	0.00122	0.00246	CcSEcCtD
Phenylephrine—Nervous system disorder—Sunitinib—pancreatic cancer	0.00122	0.00245	CcSEcCtD
Phenylephrine—Skin disorder—Sunitinib—pancreatic cancer	0.00121	0.00243	CcSEcCtD
Phenylephrine—Pulmonary oedema—Epirubicin—pancreatic cancer	0.00119	0.0024	CcSEcCtD
Phenylephrine—Skin exfoliation—Doxorubicin—pancreatic cancer	0.00118	0.00238	CcSEcCtD
Phenylephrine—Urticaria—Tamoxifen—pancreatic cancer	0.00115	0.00232	CcSEcCtD
Phenylephrine—Vision blurred—Fluorouracil—pancreatic cancer	0.00113	0.00228	CcSEcCtD
Phenylephrine—Syncope—Irinotecan—pancreatic cancer	0.00113	0.00227	CcSEcCtD
Phenylephrine—Paraesthesia—Sunitinib—pancreatic cancer	0.00112	0.00225	CcSEcCtD
Phenylephrine—Dyspnoea—Sunitinib—pancreatic cancer	0.00111	0.00223	CcSEcCtD
Phenylephrine—Loss of consciousness—Irinotecan—pancreatic cancer	0.0011	0.00222	CcSEcCtD
Phenylephrine—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.0011	0.00222	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.0011	0.0022	CcSEcCtD
Phenylephrine—Myocardial infarction—Docetaxel—pancreatic cancer	0.00109	0.00219	CcSEcCtD
Phenylephrine—Hypertension—Irinotecan—pancreatic cancer	0.00108	0.00218	CcSEcCtD
Phenylephrine—Eye pain—Epirubicin—pancreatic cancer	0.00108	0.00217	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00107	0.00216	CcSEcCtD
Phenylephrine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00107	0.00215	CcSEcCtD
Phenylephrine—Pain—Sunitinib—pancreatic cancer	0.00106	0.00214	CcSEcCtD
Phenylephrine—Hypertension—Gemcitabine—pancreatic cancer	0.00106	0.00212	CcSEcCtD
Phenylephrine—Chest pain—Gemcitabine—pancreatic cancer	0.00104	0.0021	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00103	0.00208	CcSEcCtD
Phenylephrine—Pruritus—Tamoxifen—pancreatic cancer	0.00103	0.00207	CcSEcCtD
Phenylephrine—Chest pain—Fluorouracil—pancreatic cancer	0.00102	0.00206	CcSEcCtD
Phenylephrine—Pruritus—Erlotinib—pancreatic cancer	0.00102	0.00205	CcSEcCtD
Phenylephrine—Shock—Irinotecan—pancreatic cancer	0.00101	0.00203	CcSEcCtD
Phenylephrine—Nervous system disorder—Irinotecan—pancreatic cancer	0.00101	0.00202	CcSEcCtD
Phenylephrine—Eye pain—Doxorubicin—pancreatic cancer	0.000997	0.002	CcSEcCtD
Phenylephrine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000991	0.00199	CcSEcCtD
Phenylephrine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00098	0.00197	CcSEcCtD
Phenylephrine—Skin disorder—Gemcitabine—pancreatic cancer	0.00097	0.00195	CcSEcCtD
Phenylephrine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000966	0.00194	CcSEcCtD
Phenylephrine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000963	0.00194	CcSEcCtD
Phenylephrine—Visual impairment—Docetaxel—pancreatic cancer	0.000962	0.00193	CcSEcCtD
Phenylephrine—Dizziness—Tamoxifen—pancreatic cancer	0.000961	0.00193	CcSEcCtD
Phenylephrine—Tachycardia—Fluorouracil—pancreatic cancer	0.000959	0.00193	CcSEcCtD
Phenylephrine—Dizziness—Erlotinib—pancreatic cancer	0.000951	0.00191	CcSEcCtD
Phenylephrine—Cardiac disorder—Docetaxel—pancreatic cancer	0.000926	0.00186	CcSEcCtD
Phenylephrine—Vomiting—Tamoxifen—pancreatic cancer	0.000924	0.00186	CcSEcCtD
Phenylephrine—Paraesthesia—Irinotecan—pancreatic cancer	0.000921	0.00185	CcSEcCtD
Phenylephrine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000917	0.00184	CcSEcCtD
Phenylephrine—Rash—Tamoxifen—pancreatic cancer	0.000917	0.00184	CcSEcCtD
Phenylephrine—Dermatitis—Tamoxifen—pancreatic cancer	0.000916	0.00184	CcSEcCtD
Phenylephrine—Vomiting—Erlotinib—pancreatic cancer	0.000914	0.00184	CcSEcCtD
Phenylephrine—Dyspnoea—Irinotecan—pancreatic cancer	0.000914	0.00184	CcSEcCtD
Phenylephrine—Headache—Tamoxifen—pancreatic cancer	0.000911	0.00183	CcSEcCtD
Phenylephrine—Rash—Erlotinib—pancreatic cancer	0.000907	0.00182	CcSEcCtD
Phenylephrine—Dermatitis—Erlotinib—pancreatic cancer	0.000906	0.00182	CcSEcCtD
Phenylephrine—Angiopathy—Docetaxel—pancreatic cancer	0.000905	0.00182	CcSEcCtD
Phenylephrine—Immune system disorder—Docetaxel—pancreatic cancer	0.000901	0.00181	CcSEcCtD
Phenylephrine—Headache—Erlotinib—pancreatic cancer	0.000901	0.00181	CcSEcCtD
Phenylephrine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000899	0.00181	CcSEcCtD
Phenylephrine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000897	0.0018	CcSEcCtD
Phenylephrine—Arrhythmia—Docetaxel—pancreatic cancer	0.000891	0.00179	CcSEcCtD
Phenylephrine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000891	0.00179	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000889	0.00179	CcSEcCtD
Phenylephrine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000889	0.00179	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000885	0.00178	CcSEcCtD
Phenylephrine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000882	0.00177	CcSEcCtD
Phenylephrine—Pruritus—Sunitinib—pancreatic cancer	0.000881	0.00177	CcSEcCtD
Phenylephrine—Pain—Irinotecan—pancreatic cancer	0.000877	0.00176	CcSEcCtD
Phenylephrine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000876	0.00176	CcSEcCtD
Phenylephrine—Mental disorder—Docetaxel—pancreatic cancer	0.000874	0.00176	CcSEcCtD
Phenylephrine—Nausea—Tamoxifen—pancreatic cancer	0.000863	0.00174	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000862	0.00173	CcSEcCtD
Phenylephrine—Pain—Gemcitabine—pancreatic cancer	0.000854	0.00172	CcSEcCtD
Phenylephrine—Nausea—Erlotinib—pancreatic cancer	0.000854	0.00172	CcSEcCtD
Phenylephrine—Dysgeusia—Docetaxel—pancreatic cancer	0.000851	0.00171	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000848	0.0017	CcSEcCtD
Phenylephrine—Pain—Fluorouracil—pancreatic cancer	0.00084	0.00169	CcSEcCtD
Phenylephrine—Dizziness—Sunitinib—pancreatic cancer	0.000823	0.00166	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000822	0.00165	CcSEcCtD
Phenylephrine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000822	0.00165	CcSEcCtD
Phenylephrine—Vomiting—Sunitinib—pancreatic cancer	0.000792	0.00159	CcSEcCtD
Phenylephrine—Rash—Sunitinib—pancreatic cancer	0.000785	0.00158	CcSEcCtD
Phenylephrine—Dermatitis—Sunitinib—pancreatic cancer	0.000784	0.00158	CcSEcCtD
Phenylephrine—Urticaria—Fluorouracil—pancreatic cancer	0.00078	0.00157	CcSEcCtD
Phenylephrine—Headache—Sunitinib—pancreatic cancer	0.00078	0.00157	CcSEcCtD
Phenylephrine—Syncope—Docetaxel—pancreatic cancer	0.000779	0.00157	CcSEcCtD
Phenylephrine—Palpitations—Docetaxel—pancreatic cancer	0.000768	0.00154	CcSEcCtD
Phenylephrine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000763	0.00154	CcSEcCtD
Phenylephrine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000756	0.00152	CcSEcCtD
Phenylephrine—Hypertension—Docetaxel—pancreatic cancer	0.00075	0.00151	CcSEcCtD
Phenylephrine—Chest pain—Docetaxel—pancreatic cancer	0.00074	0.00149	CcSEcCtD
Phenylephrine—Nausea—Sunitinib—pancreatic cancer	0.00074	0.00149	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000734	0.00148	CcSEcCtD
Phenylephrine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000724	0.00145	CcSEcCtD
Phenylephrine—Pruritus—Gemcitabine—pancreatic cancer	0.000707	0.00142	CcSEcCtD
Phenylephrine—Shock—Docetaxel—pancreatic cancer	0.000697	0.0014	CcSEcCtD
Phenylephrine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000695	0.0014	CcSEcCtD
Phenylephrine—Pruritus—Fluorouracil—pancreatic cancer	0.000695	0.0014	CcSEcCtD
Phenylephrine—Tachycardia—Docetaxel—pancreatic cancer	0.000692	0.00139	CcSEcCtD
Phenylephrine—Skin disorder—Docetaxel—pancreatic cancer	0.000689	0.00138	CcSEcCtD
Phenylephrine—Bradycardia—Epirubicin—pancreatic cancer	0.000685	0.00138	CcSEcCtD
Phenylephrine—Dizziness—Irinotecan—pancreatic cancer	0.000678	0.00136	CcSEcCtD
Phenylephrine—Vomiting—Irinotecan—pancreatic cancer	0.000652	0.00131	CcSEcCtD
Phenylephrine—Dizziness—Fluorouracil—pancreatic cancer	0.00065	0.00131	CcSEcCtD
Phenylephrine—Visual impairment—Epirubicin—pancreatic cancer	0.000649	0.0013	CcSEcCtD
Phenylephrine—Rash—Irinotecan—pancreatic cancer	0.000647	0.0013	CcSEcCtD
Phenylephrine—Dermatitis—Irinotecan—pancreatic cancer	0.000646	0.0013	CcSEcCtD
Phenylephrine—Headache—Irinotecan—pancreatic cancer	0.000642	0.00129	CcSEcCtD
Phenylephrine—Paraesthesia—Docetaxel—pancreatic cancer	0.000637	0.00128	CcSEcCtD
Phenylephrine—Vomiting—Gemcitabine—pancreatic cancer	0.000635	0.00128	CcSEcCtD
Phenylephrine—Bradycardia—Doxorubicin—pancreatic cancer	0.000634	0.00127	CcSEcCtD
Phenylephrine—Dyspnoea—Docetaxel—pancreatic cancer	0.000632	0.00127	CcSEcCtD
Phenylephrine—Rash—Gemcitabine—pancreatic cancer	0.00063	0.00127	CcSEcCtD
Phenylephrine—Dermatitis—Gemcitabine—pancreatic cancer	0.000629	0.00127	CcSEcCtD
Phenylephrine—Headache—Gemcitabine—pancreatic cancer	0.000626	0.00126	CcSEcCtD
Phenylephrine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000625	0.00126	CcSEcCtD
Phenylephrine—Vomiting—Fluorouracil—pancreatic cancer	0.000625	0.00126	CcSEcCtD
Phenylephrine—Rash—Fluorouracil—pancreatic cancer	0.000619	0.00125	CcSEcCtD
Phenylephrine—Dermatitis—Fluorouracil—pancreatic cancer	0.000619	0.00124	CcSEcCtD
Phenylephrine—Headache—Fluorouracil—pancreatic cancer	0.000615	0.00124	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000612	0.00123	CcSEcCtD
Phenylephrine—Angiopathy—Epirubicin—pancreatic cancer	0.000611	0.00123	CcSEcCtD
Phenylephrine—Nausea—Irinotecan—pancreatic cancer	0.000609	0.00122	CcSEcCtD
Phenylephrine—Immune system disorder—Epirubicin—pancreatic cancer	0.000608	0.00122	CcSEcCtD
Phenylephrine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000607	0.00122	CcSEcCtD
Phenylephrine—Pain—Docetaxel—pancreatic cancer	0.000606	0.00122	CcSEcCtD
Phenylephrine—Arrhythmia—Epirubicin—pancreatic cancer	0.000601	0.00121	CcSEcCtD
Phenylephrine—Visual impairment—Doxorubicin—pancreatic cancer	0.0006	0.00121	CcSEcCtD
Phenylephrine—Nausea—Gemcitabine—pancreatic cancer	0.000593	0.00119	CcSEcCtD
Phenylephrine—Mental disorder—Epirubicin—pancreatic cancer	0.00059	0.00119	CcSEcCtD
Phenylephrine—Nausea—Fluorouracil—pancreatic cancer	0.000583	0.00117	CcSEcCtD
Phenylephrine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000578	0.00116	CcSEcCtD
Phenylephrine—Tension—Epirubicin—pancreatic cancer	0.000575	0.00116	CcSEcCtD
Phenylephrine—Dysgeusia—Epirubicin—pancreatic cancer	0.000574	0.00115	CcSEcCtD
Phenylephrine—Nervousness—Epirubicin—pancreatic cancer	0.000569	0.00114	CcSEcCtD
Phenylephrine—Angiopathy—Doxorubicin—pancreatic cancer	0.000565	0.00114	CcSEcCtD
Phenylephrine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000563	0.00113	CcSEcCtD
Phenylephrine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000561	0.00113	CcSEcCtD
Phenylephrine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000556	0.00112	CcSEcCtD
Phenylephrine—Vision blurred—Epirubicin—pancreatic cancer	0.000552	0.00111	CcSEcCtD
Phenylephrine—Mental disorder—Doxorubicin—pancreatic cancer	0.000546	0.0011	CcSEcCtD
Phenylephrine—Agitation—Epirubicin—pancreatic cancer	0.000538	0.00108	CcSEcCtD
Phenylephrine—Tension—Doxorubicin—pancreatic cancer	0.000532	0.00107	CcSEcCtD
Phenylephrine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000531	0.00107	CcSEcCtD
Phenylephrine—Nervousness—Doxorubicin—pancreatic cancer	0.000527	0.00106	CcSEcCtD
Phenylephrine—Syncope—Epirubicin—pancreatic cancer	0.000525	0.00106	CcSEcCtD
Phenylephrine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000522	0.00105	CcSEcCtD
Phenylephrine—Palpitations—Epirubicin—pancreatic cancer	0.000518	0.00104	CcSEcCtD
Phenylephrine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000515	0.00104	CcSEcCtD
Phenylephrine—Vision blurred—Doxorubicin—pancreatic cancer	0.000511	0.00103	CcSEcCtD
Phenylephrine—Hypertension—Epirubicin—pancreatic cancer	0.000506	0.00102	CcSEcCtD
Phenylephrine—Pruritus—Docetaxel—pancreatic cancer	0.000502	0.00101	CcSEcCtD
Phenylephrine—Chest pain—Epirubicin—pancreatic cancer	0.000499	0.001	CcSEcCtD
Phenylephrine—Agitation—Doxorubicin—pancreatic cancer	0.000498	0.001	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000495	0.000996	CcSEcCtD
Phenylephrine—Syncope—Doxorubicin—pancreatic cancer	0.000486	0.000977	CcSEcCtD
Phenylephrine—Palpitations—Doxorubicin—pancreatic cancer	0.000479	0.000963	CcSEcCtD
Phenylephrine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000476	0.000958	CcSEcCtD
Phenylephrine—Shock—Epirubicin—pancreatic cancer	0.00047	0.000946	CcSEcCtD
Phenylephrine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000469	0.000943	CcSEcCtD
Phenylephrine—Dizziness—Docetaxel—pancreatic cancer	0.000469	0.000943	CcSEcCtD
Phenylephrine—Hypertension—Doxorubicin—pancreatic cancer	0.000468	0.000941	CcSEcCtD
Phenylephrine—Tachycardia—Epirubicin—pancreatic cancer	0.000467	0.000938	CcSEcCtD
Phenylephrine—Skin disorder—Epirubicin—pancreatic cancer	0.000464	0.000934	CcSEcCtD
Phenylephrine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000462	0.000929	CcSEcCtD
Phenylephrine—Chest pain—Doxorubicin—pancreatic cancer	0.000462	0.000928	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000458	0.000922	CcSEcCtD
Phenylephrine—Vomiting—Docetaxel—pancreatic cancer	0.000451	0.000906	CcSEcCtD
Phenylephrine—Rash—Docetaxel—pancreatic cancer	0.000447	0.000899	CcSEcCtD
Phenylephrine—Dermatitis—Docetaxel—pancreatic cancer	0.000447	0.000898	CcSEcCtD
Phenylephrine—Headache—Docetaxel—pancreatic cancer	0.000444	0.000893	CcSEcCtD
Phenylephrine—Shock—Doxorubicin—pancreatic cancer	0.000435	0.000875	CcSEcCtD
Phenylephrine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000434	0.000872	CcSEcCtD
Phenylephrine—Tachycardia—Doxorubicin—pancreatic cancer	0.000432	0.000868	CcSEcCtD
Phenylephrine—Skin disorder—Doxorubicin—pancreatic cancer	0.00043	0.000864	CcSEcCtD
Phenylephrine—Paraesthesia—Epirubicin—pancreatic cancer	0.000429	0.000863	CcSEcCtD
Phenylephrine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000428	0.00086	CcSEcCtD
Phenylephrine—Dyspnoea—Epirubicin—pancreatic cancer	0.000426	0.000857	CcSEcCtD
Phenylephrine—Nausea—Docetaxel—pancreatic cancer	0.000421	0.000847	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000413	0.00083	CcSEcCtD
Phenylephrine—Pain—Epirubicin—pancreatic cancer	0.000409	0.000822	CcSEcCtD
Phenylephrine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000397	0.000799	CcSEcCtD
Phenylephrine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000394	0.000793	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000382	0.000768	CcSEcCtD
Phenylephrine—Urticaria—Epirubicin—pancreatic cancer	0.00038	0.000764	CcSEcCtD
Phenylephrine—Pain—Doxorubicin—pancreatic cancer	0.000378	0.000761	CcSEcCtD
Phenylephrine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000352	0.000708	CcSEcCtD
Phenylephrine—Urticaria—Doxorubicin—pancreatic cancer	0.000351	0.000707	CcSEcCtD
Phenylephrine—Pruritus—Epirubicin—pancreatic cancer	0.000338	0.00068	CcSEcCtD
Phenylephrine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000326	0.000655	CcSEcCtD
Phenylephrine—Dizziness—Epirubicin—pancreatic cancer	0.000316	0.000636	CcSEcCtD
Phenylephrine—Pruritus—Doxorubicin—pancreatic cancer	0.000313	0.000629	CcSEcCtD
Phenylephrine—Vomiting—Epirubicin—pancreatic cancer	0.000304	0.000611	CcSEcCtD
Phenylephrine—Rash—Epirubicin—pancreatic cancer	0.000301	0.000606	CcSEcCtD
Phenylephrine—Dermatitis—Epirubicin—pancreatic cancer	0.000301	0.000606	CcSEcCtD
Phenylephrine—Headache—Epirubicin—pancreatic cancer	0.0003	0.000602	CcSEcCtD
Phenylephrine—Dizziness—Doxorubicin—pancreatic cancer	0.000293	0.000588	CcSEcCtD
Phenylephrine—Nausea—Epirubicin—pancreatic cancer	0.000284	0.000571	CcSEcCtD
Phenylephrine—Vomiting—Doxorubicin—pancreatic cancer	0.000281	0.000566	CcSEcCtD
Phenylephrine—Rash—Doxorubicin—pancreatic cancer	0.000279	0.000561	CcSEcCtD
Phenylephrine—Dermatitis—Doxorubicin—pancreatic cancer	0.000279	0.00056	CcSEcCtD
Phenylephrine—Headache—Doxorubicin—pancreatic cancer	0.000277	0.000557	CcSEcCtD
Phenylephrine—Nausea—Doxorubicin—pancreatic cancer	0.000263	0.000528	CcSEcCtD
Phenylephrine—ADRA1A—Signaling Pathways—GLI1—pancreatic cancer	8.85e-05	0.000668	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DTX4—pancreatic cancer	8.85e-05	0.000668	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AGTR1—pancreatic cancer	8.79e-05	0.000664	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	8.73e-05	0.000659	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SHH—pancreatic cancer	8.68e-05	0.000655	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CNR1—pancreatic cancer	8.67e-05	0.000654	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SCT—pancreatic cancer	8.64e-05	0.000652	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HEY1—pancreatic cancer	8.64e-05	0.000652	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOTCH4—pancreatic cancer	8.62e-05	0.000651	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NRP1—pancreatic cancer	8.61e-05	0.00065	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PPP2R5B—pancreatic cancer	8.61e-05	0.00065	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CD44—pancreatic cancer	8.58e-05	0.000648	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IAPP—pancreatic cancer	8.57e-05	0.000647	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—HRAS—pancreatic cancer	8.38e-05	0.000633	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—GCG—pancreatic cancer	8.37e-05	0.000632	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	8.35e-05	0.000631	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HEY2—pancreatic cancer	8.29e-05	0.000626	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCK—pancreatic cancer	8.24e-05	0.000622	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTHLH—pancreatic cancer	8.23e-05	0.000621	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTCH1—pancreatic cancer	8.23e-05	0.000621	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GCG—pancreatic cancer	8.22e-05	0.000621	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GAST—pancreatic cancer	8.09e-05	0.000611	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CNR2—pancreatic cancer	8.03e-05	0.000606	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GLP1R—pancreatic cancer	8.03e-05	0.000606	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—CXCL8—pancreatic cancer	8.03e-05	0.000606	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	8.02e-05	0.000606	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AGTR1—pancreatic cancer	7.99e-05	0.000603	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCKAR—pancreatic cancer	7.9e-05	0.000597	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—STK11—pancreatic cancer	7.73e-05	0.000584	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SCT—pancreatic cancer	7.67e-05	0.000579	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HEY1—pancreatic cancer	7.67e-05	0.000579	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—JAG2—pancreatic cancer	7.66e-05	0.000579	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MEN1—pancreatic cancer	7.55e-05	0.00057	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SST—pancreatic cancer	7.53e-05	0.000568	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CG—pancreatic cancer	7.42e-05	0.00056	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	7.42e-05	0.00056	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—JAG1—pancreatic cancer	7.36e-05	0.000556	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOTCH3—pancreatic cancer	7.33e-05	0.000554	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCK—pancreatic cancer	7.32e-05	0.000553	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SHH—pancreatic cancer	7.2e-05	0.000544	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PRSS1—pancreatic cancer	7.16e-05	0.000541	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOTCH4—pancreatic cancer	7.16e-05	0.000541	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CNR2—pancreatic cancer	7.13e-05	0.000539	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GLP1R—pancreatic cancer	7.13e-05	0.000539	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CXCL8—pancreatic cancer	7.13e-05	0.000538	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IAPP—pancreatic cancer	7.11e-05	0.000537	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCKAR—pancreatic cancer	7.02e-05	0.00053	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CNR1—pancreatic cancer	6.94e-05	0.000524	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTHLH—pancreatic cancer	6.83e-05	0.000516	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTCH1—pancreatic cancer	6.83e-05	0.000516	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—JAG2—pancreatic cancer	6.81e-05	0.000514	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CG—pancreatic cancer	6.74e-05	0.000509	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GCG—pancreatic cancer	6.71e-05	0.000506	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MEN1—pancreatic cancer	6.71e-05	0.000506	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—TYMS—pancreatic cancer	6.65e-05	0.000502	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CD—pancreatic cancer	6.52e-05	0.000493	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AGTR1—pancreatic cancer	6.4e-05	0.000483	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SHH—pancreatic cancer	6.4e-05	0.000483	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOTCH4—pancreatic cancer	6.36e-05	0.00048	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IAPP—pancreatic cancer	6.32e-05	0.000477	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STK11—pancreatic cancer	6.31e-05	0.000476	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SST—pancreatic cancer	6.25e-05	0.000472	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ARG2—pancreatic cancer	6.21e-05	0.000469	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.16e-05	0.000465	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—JAG1—pancreatic cancer	6.11e-05	0.000462	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOTCH3—pancreatic cancer	6.09e-05	0.00046	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTHLH—pancreatic cancer	6.07e-05	0.000458	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTCH1—pancreatic cancer	6.07e-05	0.000458	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CD—pancreatic cancer	5.93e-05	0.000447	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CNR1—pancreatic cancer	5.76e-05	0.000435	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CB—pancreatic cancer	5.69e-05	0.000429	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CG—pancreatic cancer	5.59e-05	0.000422	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GCG—pancreatic cancer	5.57e-05	0.00042	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SST—pancreatic cancer	5.55e-05	0.000419	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SMAD4—pancreatic cancer	5.52e-05	0.000417	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.47e-05	0.000413	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CXCL8—pancreatic cancer	5.47e-05	0.000413	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—JAG1—pancreatic cancer	5.43e-05	0.00041	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TYMP—pancreatic cancer	5.43e-05	0.00041	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.42e-05	0.000409	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—APOE—pancreatic cancer	5.41e-05	0.000408	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOTCH3—pancreatic cancer	5.41e-05	0.000408	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HES1—pancreatic cancer	5.39e-05	0.000407	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AGTR1—pancreatic cancer	5.31e-05	0.000401	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STK11—pancreatic cancer	5.23e-05	0.000395	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CB—pancreatic cancer	5.16e-05	0.00039	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CNR1—pancreatic cancer	5.12e-05	0.000387	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CG—pancreatic cancer	4.97e-05	0.000375	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CXCL8—pancreatic cancer	4.96e-05	0.000375	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GCG—pancreatic cancer	4.94e-05	0.000373	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CD—pancreatic cancer	4.92e-05	0.000371	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CG—pancreatic cancer	4.88e-05	0.000369	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.81e-05	0.000363	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TERT—pancreatic cancer	4.73e-05	0.000357	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.72e-05	0.000356	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AGTR1—pancreatic cancer	4.72e-05	0.000356	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PPARG—pancreatic cancer	4.71e-05	0.000356	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STK11—pancreatic cancer	4.65e-05	0.000351	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SMAD4—pancreatic cancer	4.58e-05	0.000346	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CXCL8—pancreatic cancer	4.54e-05	0.000343	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HIF1A—pancreatic cancer	4.52e-05	0.000341	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TSC2—pancreatic cancer	4.51e-05	0.00034	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.48e-05	0.000338	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HES1—pancreatic cancer	4.48e-05	0.000338	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOE—pancreatic cancer	4.41e-05	0.000333	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	4.38e-05	0.00033	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CD—pancreatic cancer	4.37e-05	0.00033	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KDR—pancreatic cancer	4.32e-05	0.000326	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—DPYD—pancreatic cancer	4.31e-05	0.000325	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CD—pancreatic cancer	4.29e-05	0.000324	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CB—pancreatic cancer	4.29e-05	0.000324	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.19e-05	0.000317	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CXCL8—pancreatic cancer	4.12e-05	0.000311	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NFKBIA—pancreatic cancer	4.11e-05	0.00031	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	4.09e-05	0.000308	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	4.07e-05	0.000307	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOTCH1—pancreatic cancer	4.07e-05	0.000307	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.04e-05	0.000305	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	4.03e-05	0.000304	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CG—pancreatic cancer	3.98e-05	0.000301	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—NRAS—pancreatic cancer	3.98e-05	0.000301	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	3.98e-05	0.0003	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGF—pancreatic cancer	3.94e-05	0.000297	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TERT—pancreatic cancer	3.92e-05	0.000296	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.9e-05	0.000295	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	3.81e-05	0.000288	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HIF1A—pancreatic cancer	3.75e-05	0.000283	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TSC2—pancreatic cancer	3.74e-05	0.000283	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CB—pancreatic cancer	3.74e-05	0.000282	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS2—pancreatic cancer	3.71e-05	0.00028	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOE—pancreatic cancer	3.66e-05	0.000277	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	3.66e-05	0.000276	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—EGFR—pancreatic cancer	3.63e-05	0.000274	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KDR—pancreatic cancer	3.59e-05	0.000271	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.55e-05	0.000268	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CD—pancreatic cancer	3.5e-05	0.000264	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	3.48e-05	0.000263	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.47e-05	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—KRAS—pancreatic cancer	3.43e-05	0.000259	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NFKBIA—pancreatic cancer	3.41e-05	0.000258	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOTCH1—pancreatic cancer	3.38e-05	0.000255	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	3.33e-05	0.000252	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	3.32e-05	0.000251	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CG—pancreatic cancer	3.3e-05	0.00025	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—NRAS—pancreatic cancer	3.3e-05	0.00025	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGF—pancreatic cancer	3.27e-05	0.000247	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	3.25e-05	0.000246	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTEN—pancreatic cancer	3.23e-05	0.000244	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	3.19e-05	0.000241	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CD44—pancreatic cancer	3.16e-05	0.000239	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CA—pancreatic cancer	3.15e-05	0.000238	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.1e-05	0.000234	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.07e-05	0.000232	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CB—pancreatic cancer	3.05e-05	0.00023	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GCG—pancreatic cancer	3.03e-05	0.000229	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	3.03e-05	0.000229	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—EGFR—pancreatic cancer	3.01e-05	0.000227	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	3e-05	0.000227	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	2.94e-05	0.000222	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	2.94e-05	0.000222	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCL8—pancreatic cancer	2.93e-05	0.000221	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HRAS—pancreatic cancer	2.91e-05	0.00022	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CD—pancreatic cancer	2.91e-05	0.000219	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	2.9e-05	0.000219	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.88e-05	0.000217	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—STK11—pancreatic cancer	2.85e-05	0.000215	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	2.84e-05	0.000215	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT1—pancreatic cancer	2.83e-05	0.000214	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CASP3—pancreatic cancer	2.81e-05	0.000212	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCND1—pancreatic cancer	2.73e-05	0.000206	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CTNNB1—pancreatic cancer	2.7e-05	0.000204	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.68e-05	0.000202	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	2.67e-05	0.000202	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP9—pancreatic cancer	2.65e-05	0.0002	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTEN—pancreatic cancer	2.64e-05	0.000199	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	2.61e-05	0.000197	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	2.58e-05	0.000195	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT1—pancreatic cancer	2.57e-05	0.000194	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.56e-05	0.000193	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	2.53e-05	0.000191	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	2.53e-05	0.000191	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.45e-05	0.000185	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SRC—pancreatic cancer	2.44e-05	0.000185	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	2.43e-05	0.000184	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	2.42e-05	0.000183	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—pancreatic cancer	2.38e-05	0.00018	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STAT3—pancreatic cancer	2.36e-05	0.000178	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NRAS—pancreatic cancer	2.35e-05	0.000178	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	2.35e-05	0.000178	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	2.33e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.32e-05	0.000175	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CA—pancreatic cancer	2.28e-05	0.000172	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	2.27e-05	0.000171	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	2.25e-05	0.00017	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	2.24e-05	0.00017	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	2.2e-05	0.000166	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MYC—pancreatic cancer	2.19e-05	0.000165	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	2.19e-05	0.000165	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TGFB1—pancreatic cancer	2.19e-05	0.000165	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	2.16e-05	0.000163	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	2.15e-05	0.000162	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	2.14e-05	0.000162	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	2.13e-05	0.000161	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	2.09e-05	0.000158	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	2.07e-05	0.000156	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	2.03e-05	0.000153	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	2.02e-05	0.000153	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	2.01e-05	0.000152	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOE—pancreatic cancer	2e-05	0.000151	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.99e-05	0.000151	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	1.98e-05	0.000149	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	1.96e-05	0.000148	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	1.95e-05	0.000148	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	1.95e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	1.94e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	1.9e-05	0.000143	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.89e-05	0.000143	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKT1—pancreatic cancer	1.86e-05	0.000141	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	1.86e-05	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	1.82e-05	0.000137	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	1.81e-05	0.000137	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	1.8e-05	0.000136	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.8e-05	0.000136	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	1.8e-05	0.000136	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	1.78e-05	0.000134	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	1.76e-05	0.000133	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	1.74e-05	0.000131	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.74e-05	0.000131	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	1.73e-05	0.000131	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	1.72e-05	0.00013	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	1.68e-05	0.000127	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	1.62e-05	0.000122	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	1.61e-05	0.000122	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.58e-05	0.00012	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	1.58e-05	0.000119	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	1.54e-05	0.000117	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	1.52e-05	0.000115	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	1.49e-05	0.000113	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	1.49e-05	0.000113	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	1.43e-05	0.000108	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.38e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.37e-05	0.000104	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.37e-05	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	1.33e-05	0.0001	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	1.27e-05	9.58e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	1.26e-05	9.52e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.19e-05	9e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	1.12e-05	8.46e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	8.41e-06	6.35e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKT1—pancreatic cancer	6.87e-06	5.19e-05	CbGpPWpGaD
